Company
ChinaNanjing Libravo Pharmaceutical Co., Ltd., Nanjing, China – FDA Inspections
Inspection records and compliance data for Nanjing Libravo Pharmaceutical Co., Ltd. in Nanjing. 1 FDA inspection on record, 1 Form 483, last inspected July 17, 2026.
Company Profile
This profile covers Nanjing Libravo Pharmaceutical Co., Ltd. based in Nanjing, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected July 17, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 17, 2026 | Not classified | Human Drugs | 1328102 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Prof. Binghe Xu
Suzhou Guochen Biotek Co., Ltd
Cisen Pharmaceuticals Co Ltd
Binhai Gaolou Chemical Co. Ltd.
Weiwei Ouyang
Guangdong CR Shunfeng Pharmaceutical Co., Ltd.
Jin Zhang, MD, PhD
Jiangsu Dedi Medical Device Co., Ltd.
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Shenyang Wanbang Tiansheng Biotechnology Co.,Ltd
Company Information
Name
Nanjing Libravo Pharmaceutical Co., Ltd.
FEI Number
3023331122
Address
310 Chongfu Road, Changlu Street, Changlu Zhen Liuhe District, Nanjing, China
Country
China
ID: 9cc39b62-902e-471d-ac5b-b494670d2a4d